ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Keros upsizes IPO, raising $96M for midphase trials
April 13, 2020Keros Therapeutics has braved a turbulent market to pull off an IPO, hitting the top end of its price range and selling 20% more shares than originally planned. -
Hematological Malignancy Risk Up for First-Degree Relatives
August 13, 2019First-degree relatives of patients with hematological malignancies have increased relative risks for the same tumor types and some different hematological malignancies, according to a study published online in Blood.
Pharma Sources Insight January 2025
